4//SEC Filing
Meltz Mark A 4
Accession 0001209191-23-034444
CIK 0001797768other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:00 PM ET
Size
5.3 KB
Accession
0001209191-23-034444
Insider Transaction Report
Form 4
Meltz Mark A
COO General Counsel Treasurer
Transactions
- Tax Payment
Common Stock
2023-06-01$4.30/sh−541$2,326→ 29,218 total
Footnotes (3)
- [F1]The shares were forfeited to cover a tax obligation resulting form the quarterly vesting of RSU's granted to the Reporting Person by the Issuer.
- [F2]Includes 20,313 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date.
- [F3]Includes 2,473 shares acquired under the Issuers Employee Stock Purchase Plan in May 2023.
Documents
Issuer
Kinnate Biopharma Inc.
CIK 0001797768
Entity typeother
Related Parties
1- filerCIK 0001771329
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:00 PM ET
- Size
- 5.3 KB